Search Results
Mar 12, 2026, 10:16 ET Global Diagnostic Imaging Equipment Market is Projected to Cross USD 80 Billion by 2034 Due to the Rising Demand for Advanced Imaging Technologies | DelveInsight
GE HealthCare, Koninklijke Philips N.V., DIGIRAD CORPORATION, Neusoft Corporation, CANON MEDICAL SYSTEMS CORPORATION, SurgicEye GmbH, DDD-Diagnostic A/S, CMR Naviscan, Mediso Ltd., Shimadzu Corporation, MR Solutions, segamicorp, Spectrum Dynamics Medical, Cardinal Health, Curium SAS, BCL X-Ray Canada
More news about: DelveInsight Business Research, LLP
Mar 12, 2026, 10:15 ET TRUE RELIGION REUNITES WITH MEGAN THEE STALLION AND DEBUTS KEY GLOCK FOR SPRING 2026 "MAKE IT TRUE" CAMPAIGN
Color Glitch story. Signature red-stitch denim returns through statement pieces like "Spicy Shorts" for the Hotties, while soft early-2000s pinks collide with electric neons to create a high-impact summer aesthetic that celebrates both legacy and evolution.This moment signals the start
More news about: True Religion
Mar 12, 2026, 10:07 ET B3 reaches major milestone with new cloud-native CSD system from Vermiculus
second year in a row, Vermiculus and B3 have successfully brought a major phase of this program into production, delivering significant market value to B3's operations as well as new features used daily by its market participants.With the new platform, B3 is positioned to support the growth of the
More news about: VermiculusFT
Mar 12, 2026, 10:00 ET NJM Insurance Group Welcomes Joseph S. Colalillo to Board of Directors
WEST TRENTON, N.J., March 12, 2026 /PRNewswire/ -- Joseph S. Colalillo, President of ShopRite of Hunterdon County, has been elected to join the Board of Directors of NJM Insurance Group.
More news about: NJM Insurance Group
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO). Such investors are advised to contact Danielle Peyton at
More news about: Pomerantz LLP
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. - AI
expenditures related to severance, other one-time termination benefits, and non-cash expenditures related to stock-based compensation." On this news, C3's stock price fell $1.91 per share, or 18.53%, to close at $8.40 per share on February 26, 2026.Pomerantz LLP, with offices in New York, Chicago,
More news about: Pomerantz LLP
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Apollo Global Management, Inc. of Class Action Lawsuit and Upcoming Deadlines - APO
Management executives including chief Marc Rowan held wide-ranging discussions over the firm's tax arrangements with Jeffrey Epstein throughout the 2010s, despite the private capital firm having previously said it 'never did any business' with" Epstein. On this news, Apollo's stock price fell $7.69
More news about: Pomerantz LLP
Mar 12, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Oracle Corporation of Class Action Lawsuit and Upcoming Deadlines - ORCL
rating, free cash flow, and ability to fund its projects, among other concerns.Per the allegations in the complaint, on September 24, 2025, S&P Global Ratings warned that OpenAI "could account for more than a third of total Oracle revenues by fiscal 2028 and even a greater share by fiscal 2030,"
More news about: Pomerantz LLP
Mar 12, 2026, 10:00 ET Exodus Brings Crypto Signing Bonuses to MoonPay X Games League Summer Draft
bonuses in stablecoins.XO Cash is a fully reserved, USD-backed stablecoin issued and managed by MoonPay and built on M0's open stablecoin infrastructure. The stablecoin will also serve as a liquidity layer for
More news about: MoonPay
Mar 12, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; (iv) accordingly, INO-3107's overall regulatory and commercial prospects were overstated; and (v) as a result, Defendants' public statements were materially false and misleading
More news about: Pomerantz LLP
Mar 12, 2026, 09:43 ET B3 reaches major milestone with new cloud-native CSD system from Vermiculus
second year in a row, Vermiculus and B3 have successfully brought a major phase of this program into production, delivering significant market value to B3's operations as well as new features used daily by its market participants.With the new platform, B3 is positioned to support the growth of the
More news about: VermiculusFT
Mar 12, 2026, 09:43 ET decision44 to Define the Next Era of AI-Powered Supply Chain Execution
and driving smarter collaboration across the extended supply chain.decision44 will also debut the next wave of AI-powered capabilities from project44's Decision Intelligence Platform, including new tools designed to automate workflows, resolve exceptions faster, and support smarter tradeoffs across
More news about: project44
Mar 12, 2026, 09:15 ET APO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Apollo Global Management (APO) Investors of Securities Class Action Deadline on May 1, 2026
disclose that: (1) Defendants Rowan and Black, among other leadership figures at Apollo Global, frequently communicated with Jeffrey Epstein in the 2010s regarding Apollo Global's business; (2) as a result, Apollo Global's assertion that the Company had never done business with Jeffrey Epstein was untrue;
More news about: Faruqi & Faruqi, LLP
Mar 12, 2026, 09:15 ET Giant Worldwide Supports Oscar-Nominated Films From NEON and A24 With Global Distribution Services
preparation, in addition to digital distribution packaging. Giant also created master encodes, in addition to digital platform deliveries.For A24's awards contenders Marty Supreme and If I Had Legs I'd Kick You, Giant provided master QC, encoding, metadata preparation, and digital
More news about: Cineverse Corp.
Mar 12, 2026, 09:15 ET New Peer-Reviewed Research Shows Comprehensive Care Model Drives Superior GLP-1 Outcomes
https://www.sciencedirect.com/science/article/pii/S2667368125000324Tirzepatide study: "Weight reduction and treatment adherence with tirzepatide using the Individualized Virtual
More news about: Ivim Health
Mar 12, 2026, 09:15 ET NatGold Digital Signs $20M Definitive Agreement to Acquire Historic Idaho Gold Project, Targeting 73% Token Minting Share
first mining claims were staked and numerous historical workings were excavated across the property.Modern exploration began in the early 1980s and included stream sediment sampling, soil sampling, outcrop and dump sampling, geological mapping, reverse circulation and diamond drill holes, metallurgical
More news about: NatGold Digital Ltd.
Mar 12, 2026, 09:11 ET Resolutions of Kojamo plc's Annual General Meeting and the organizing meeting of the Board of Directors; Kojamo's new business name Lumo Homes plc
https://news.cision.com/kojamo-oyj/r/resolutions-of-kojamo-plc-s-annual-general-meeting-and-the-organizing-meeting-of-the-board-of-direct,c4320413
More news about: Kojamo Oyj
Mar 12, 2026, 09:05 ET Společnost Haier Biomedical pořádá v Římě evropský partnerský summit a rozvíjí strategii „V Evropě, pro Evropu"
integrují skladování při ultranízkých teplotách s podporou RFID, modulární automatizační platformy a systémy kapalného dusíku, které zvyšují sledovatelnost vzorků a provozní efektivitu. Řešením problémů, jako jsou integrita vzorků, sledování teploty a skladování s vysokou hustotou, se společnost zařadila do
More news about: Haier Biomedical
Mar 12, 2026, 09:00 ET S-Docs for HubSpot achieves SOC 2 Type II compliance, enhancing enterprise-grade security across its solutions
at S-Docs, and protecting customer data has always been a top priority for our team," said Brian Stimpfl, CEO of S-Docs. "As organizations face growing regulatory pressure and increasingly complex document workflows, security can't be an afterthought. Achieving SOC 2 Type II compliance for our S-Docs
More news about: S-Docs
Mar 12, 2026, 09:00 ET SitecoreAI Recognized by Industry Experts and Practitioners as a Proven Platform for Marketing Teams to Reach, Engage, and Serve Customers
excellence in cloud computing since 2011. About G2's Best Software Awards G2's 2026 Best Software Awards feature dozens of award lists, ranking software vendors and products using G2's proprietary algorithm. The results are based on G2's verified user reviews and publicly available market
More news about: Sitecore
Mar 12, 2026, 09:00 ET SUEWALLST: NUSCALE CEO AND CFO FACE PERSONAL LIABILITY FOR SMR LOSSES
during which they allegedly made materially misleading representations about ENTRA1's qualifications as a nuclear power plant developerHad access to information revealing ENTRA1's lack of operational history prior to or shortly after issuing public statements touting
More news about: SueWallSt.com
Mar 12, 2026, 09:00 ET Silicon Motion Launches SM8008, the Industry's First Purpose-Built PCIe Gen5 Controller for Enterprise Boot Drive and Ultra-Low-Power Storage
Up to 14GB/s sequential throughputOver 2.3 million random IOPS (4K)Active power consumption under 5WPCIe Gen5 x4 host interface8 NAND channels supporting ONFI and Toggle DDR 5.0 up to 3,600MT/sIt supports single
More news about: Silicon Motion Technology Corporation
Mar 12, 2026, 09:00 ET This billionaire-backed founder residency will pay you to come to Austin and provide everything you need to build the next fintech unicorn
PEAK6, the Austin-based fintech operating company, announces the launch of PEAK6 Trials, a one-year founder residency program based at PEAK6's headquarters inclusive of a $100,000 salary, with direct access to PEAK6 internal resources and network of potential customers.AUSTIN,
More news about: PEAK6
Mar 12, 2026, 09:00 ET Aminex Therapeutics Receives Second FDA Orphan Drug Designation for AMXT 1501 for Malignant Glioma Including DIPG - a Highly Aggressive Childhood Brain Cancer
"This second Orphan Drug Designation is a powerful validation of AMXT 1501's potential to make a meaningful difference for patients facing some of the most devastating cancers," said Mark Burns, PhD, Chief Scientific Officer
More news about: Aminex Therapeutics, Inc.
Mar 12, 2026, 09:00 ET BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt
gy-volumes---boston-scientific-corporation-investors-face-losses-following-claims-executives-misrepresented-us-electrophysiology-volumes-suewallst-302711916.htmlSOURCE SueWallSt.com
More news about: SueWallSt.com